Not yet recruiting |
: Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
: - Acute Lymphoblastic Leukemia in Complete Remission
- Lymphoblastic Lymphoma in Complete Remiss
: 2015-09-30
: Drug: Ixazomib Patients who have been on stable doses of 6 - MP, vincristine, and methotrexate for a min
|
Terminated |
: Phase I Study Of Vincristine, Doxorubicin, And Dexamethasone (VXD) Plus Ixazomib In Adults With Relapsed Or Refractory Acute Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
: - Relapsed or Refractory Acute Lymphoblastic Leukemia
- Relapsed or Refractory Lymphoblastic Lym
: 2013-06-05
: - Drug: MLN9708
- Drug: Vincristine
|
Recruiting |
: Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
: - Acute Leukemia of Ambiguous Lineage
- Childhood B Acute Lymphobla
: 2016-07-07
: - Drug: Azacitidine Given IV
|
Recruiting |
: A Phase 2 Study of Clofarabine, Idarubicin, Cytarabine, Vincristine, and Corticosteroids - Mixed Phenotype Acute Leukemia (MPAL)
: Leukemia
: 2014-05-08
:
|
Active, not recruiting |
: Laboratory-Treated Donor Cord Blood Cell Infusion Following Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
: - Acute Leukemia of Ambiguous Lineage
- Adult Acute Myeloid Leukemi
: 2012-10-03
: - Drug: Cytarabine Given IV
|
Recruiting |
: GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
: - Leukemia, Acute Lymphoblastic
- Acute Myeloid Leukemia
-
: 2016-06-09
: - Procedure: Allogeneic stem cell transplantation
|
Terminated |
: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
: - Mixed Lineage Acute Leukemia
- Acute Myeloid Leukemia
: 2015-04-14
: - Drug: Bortezomib Bortezomib wi
|
Completed |
: Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia
: - Acute Leukemias of Ambiguous Lineage
- Philadelphia Chromosome Ne
: 2010-05-26
: - Drug: entinostat Given PO
|
Recruiting |
: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
: - Acute Biphenotypic Leukemia
- Acute Myeloid Leukemia
: 2016-03-14
: - Drug: Cladribine Given IV
|
Active, not recruiting |
: Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
: - Acute Biphenotypic Leukemia
- Acute Myeloid Leukemia
: 2013-03-01
: - Other: Laboratory Biomarker Analysis
|